Diagnosis and treatment understanding of Waldenstrom macroglobulinemia in China:a cross sectional study  

作　　者：YI Shuhua 易树华(State Key Lab Experiment Hematol,Natl Clin Blood Dis Res Center,Haihe Cell Ecosys Lab,Instit Hematol&Blood Dis Hosp,CAMS&PUMC,Tianjin 300020,China)

机构地区：[1]State Key Lab Experiment Hematol,Natl Clin Blood Dis Res Center,Haihe Cell Ecosys Lab,Instit Hematol&Blood Dis Hosp,CAMS&PUMC,Tianjin 300020,China

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第3期186-187,共2页中国医学文摘（内科学分册英文版）

摘　　要：Objective To conduct a nationwide physician survey to better understand clinicians'disease awareness,treatment patterns,and experience of Waldenstrom macroglobulinemia(WM) in China.Methods This cross-sectional study was conducted from February 2022 to July 2022 by recruiting clinicians with WM treatment experience from hematology,hematology-oncology,and oncology departments throughout China.

关 键 词：GLOBULIN China. TREATMENT 

分 类 号：R554[医药卫生—血液循环系统疾病]